Benzinga | Aug 4, 2021 04:51AM EDT

SVB Leerink Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $196

SVB Leerink analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and lowers the price target from $205 to $196.